DrugPatentWatch Database Preview
Taro Pharms Company Profile
What is the competitive landscape for TARO PHARMS, and what generic alternatives to TARO PHARMS drugs are available?
TARO PHARMS has fourteen approved drugs.
There are three US patents protecting TARO PHARMS drugs.
There are nineteen patent family members on TARO PHARMS drugs in twelve countries and twenty-nine supplementary protection certificates in eleven countries.
Summary for Taro Pharms
| International Patents: | 19 |
| US Patents: | 3 |
| Tradenames: | 12 |
| Ingredients: | 12 |
| NDAs: | 14 |
Drugs and US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharms | OXICONAZOLE NITRATE | oxiconazole nitrate | CREAM;TOPICAL | 205076-001 | Mar 7, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | AT | RX | Yes | Yes | 8,715,624 | Start Trial | Y | Start Trial | ||
| Taro Pharms | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | benzoyl peroxide; clindamycin phosphate | GEL;TOPICAL | 206218-001 | Dec 15, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharms | TRETINOIN | tretinoin | CREAM;TOPICAL | 211644-001 | Jan 25, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Taro Pharms | TRETINOIN | tretinoin | CREAM;TOPICAL | 211645-001 | Jan 22, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | Start Trial |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | Start Trial |
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 6,528,086 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Taro Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2012246315 | Start Trial |
| Canada | 2609579 | Start Trial |
| Japan | 2007217431 | Start Trial |
| Denmark | 1244401 | Start Trial |
| China | 1376043 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1586316 | 122011100019 | Germany | Start Trial | PRODUCT NAME: BROMFENAC (2-AMINO-3-(4-BROMOBENZOYL)PHENYLESSIGSAEURE); REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
| 0186118 | SPC/GB05/029 | United Kingdom | Start Trial | PRODUCT NAME: MESOTRIONE (2-(4-METHYLSULPHONYL-2-NITROBENZOYL)-1,3CYCLOHEXANEDIONE); REGISTERED: AU 2726 20001016; UK 0309 OF 2005 20050218 |
| 0617614 | SPC/GB01/014 | United Kingdom | Start Trial | PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018 |
| 1304992 | CR 2013 00053 | Denmark | Start Trial | PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322 |
| 0617614 | 11/2001 | Austria | Start Trial | PRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
